Skip to main content
logo
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
59.81
+0.64 (1.08%)
At close: Aug 10, 2026, 4:00 PM EDT
60.17
+0.36 (0.60%)
Pre-market: Aug 11, 2026, 7:31 AM EDT

Moderna Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3,151-2,822-3,561-4,7148,36212,202
Depreciation & Amortization
241215189621348232
Stock-Based Compensation
462483429305226142
Other Adjustments
21817-1959-264
Change in Receivables
131565344931,790-1,784
Changes in Inventories
-38-3483747492-1,394
Changes in Accounts Payable
-17-92-6913240204
Changes in Accrued Expenses
868-2-385-340612989
Changes in Income Taxes Payable
-----876
Changes in Unearned Revenue
16841-439-2,060-4,1572,824
Changes in Other Operating Activities
3791641981,836-2,991-407
Operating Cash Flow
-1,073-1,873-3,004-3,1184,98113,620
Operating Cash Flow Growth
-----63.43%571.93%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-171-192-1,051-707-400-284
Purchases of Intangible Assets
--10----
Purchases of Investments
-4,613-5,768-6,529-3,783-11,475-12,682
Proceeds from Sale of Investments
5,6897,9169,5298,7816,6994,443
Cash Acquisitions
----85--
Investing Cash Flow
9051,9461,9494,206-5,176-8,523

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-600----
Net Short-Term Debt Issued (Repaid)
-600----
Issuance of Common Stock
6035664665124
Repurchase of Common Stock
-----3,329-857
Net Common Stock Issued (Repurchased)
60356646-3,264-733
Other Financing Activities
-27-42-10-1,423-184-140
Financing Cash Flow
61159356-1,377-3,448-873

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2----
Net Cash Flow
443668-999-289-3,6434,224

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,244-2,065-4,055-3,8254,58113,336
Free Cash Flow Growth
-----65.65%580.75%
FCF Margin
-55.83%-106.22%-125.31%-55.86%23.78%72.20%
Free Cash Flow Per Share
-3.16-5.31-10.56-10.0111.0130.94
Levered Free Cash Flow
-1,721-2,122-5,035-4,6042,50615,242
Unlevered Free Cash Flow
-1,959-3,034-5,369-4,9592,37115,252
SEC Filings: 10-K · 10-Q